Pharmacokinetics of Octreotide in Patients With Cirrhosis and Portal Hypertension; Relationship Between the Plasma Levels of the Analogue and the Magnitude and Duration of the Reduction in Corrected Wedged Hepatic Venous Pressure release_w3uqnv6sf5ajno3yqufpcma5uu

by S. A. Jenkins, D. M. Nott, J. N. Baxter


NOTE: currently batch computed and may include additional references sources, or be missing recent changes, compared to entity reference list.
Fuzzy reference matching is a work in progress!
Read more about quality, completeness, and caveats in the fatcat guide.
Showing 1 - 30 of 31 references (in 89ms)

via fuzzy
Metabolic Clearance and Plasma Half-Disappearance Time of Exogenous Somatostatin in Man*
1979   Journal of Clinical Endocrinology and Metabolism
doi:10.1210/jcem-48-1-50  pmid:422706 

via grobid
Veber, D. F., Freidinger, R. M., Schwenk-Perlow, R. et al. (1981). A potent cyclic hexapeptide analogue of somatostatin. Nature, 292, 55-58.

via grobid
Rosenthal, L. E., Yamashiro, D. J., Rivier, J. et al. (1983).

via grobid
Structure-activity relationship of somatoastatin analo- gues in the rabbit ileum and rat colon. J. Clin. Invest., 71, 840-849.

via grobid
del Pozo, E., Neufield, M., Schlutr, K. et al. (1986). Endocrine profile of a long acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administration. Acta Endocri- nologica, 111, 433-439.

via grobid
Kutz, K., Nuesch, E. and Rosenthaler, J. (1986). Pharmacokinetics of SMS 201-995 in healthy subjects.

via grobid
Scan J. Gastroenterology, 21 (sup 119), 65-72.

via grobid
Erikson, L. S., Brundin, T., Soderlund, C. and Wahren, J. (1987). Haemodynamic effects of a long-standing somatostatin analogue in patients with liver cirrhosis.

via grobid
Scand. J. Gastroent., 22, 919-925.

via grobid
Tyden, G., Samnegaard, H., Thulin, L. and Friman, L. (1978). Treatment of bleeding oesophageal varices with somatostatin. New Engl. J. Med., 22, 919-925.

via grobid
Bories, P., Pomier-Layragues, G., Chotard, J. P., Jacob, C. and Michel, H. (1980). Lasomotostatine dimue l'hypertension portale chez le cirrhotique. Gastroenter- ologie et Biologique, 4, 616-617.

via grobid
Bosch, J., Kravetz, D. and Rhodes, J. (1981). Effects of somatostatin on hepatic and systemic haemodynamics in patients with cirrhosis of the liver; comparison with vasopressin. Gastroenterology, 80, 518-525.

via grobid
Naeije, R., Hallemans, R., Mois, P., Melot, C. H. and Reding, P. (1982). Effects of vasopressin and somato- statin on haemodynamics and blood gases in patients with liver cirrhosis. Crit. Care Med., 10, 578-582.

via grobid
Eriksson, L. S., Law, D., Sato, Y. and Wahren, J. (1984). Influence of somatostatin on splanchnic haemo- dynamics in patients with liver cirrhosis. Clinic Physiol., 4, 5 11.

via grobid
Navasa, M., Bosch, J., Chesta, J. et al. (1988). Haemo- dynamics effect of subcutaneous administration of SMS 201-995, a long-acting somatostatin analogue in patients with cirrhosis and portal hypertension.

via grobid
J. Hepatol., 64, 123.

via grobid
Pringle, S. D., McKee, R. F., Garden, O. J., Lorimer, P. R. and Carter, D. C. (1988). The effects of a long-acting somatostatin analogue on portal and systemic hameo- dynamics in cirrhosis. Alimentary Pharmacol and Ther- apeutics, 2, 451-459.

via grobid
Merkel, C., Gatta, A., Zuin, R. et al. (1985). Effect of somatostatin on splanchnic haemodynamics in patients with cirrhosis of the liver and portal hypertension. Digestion, 32, 92-98.

via grobid
Sonnenberg, G. E., Keller, U., Perruchoud, A., Bur- khardt, D. and Gyr, K. (1981). Effect of somatostatin on splanchnic haemodynamics in patients with cirrhosis of the liver and in normal subjects. Gastroenterology, 80, 526-532.

via grobid
Burroughs, A. K., Santana, J. A., Dux, T., Dick R. and McIntyre, N. (1985). Effect of a long-acting analogue of somatostatin (SMS 201-995) on hepatic venous pres- sures and azygos blood flow in cirrhotics. Gastroenter- ology, 26, 562.

via grobid
McCormick, P. A., Dick, R., Siringo, S. et al. (1990). Octreotide reduces azygos blood flow in cirrhotic patients with portal hypertension. Eur. J. Gastroenterol and Hepatol., 2, 489-492.

via grobid
Hanisch, E., Doertenbach, J. and Usadel, K. H. (1992). Somatostatin in acute bleeding oesophageal varices. Pharmacology and Rationale for use. Drugs, 44 (sup 2), 24-35.

via grobid
Samnegaard, H., Thulin, L., Andreen, M. et al. (1979). Circulatory effects of somatostatin on anaesthetized dogs. Acta Chir Scand, 145, 209-212.

via grobid
Marbach, P., Briner, U., Lemaire, M., Schweitzer, A. and Teraski, T. (1993). From somatostatin to sandosta- tin; pharmacodynamics and pharmacokinetics. Diges- tion, 5 (sup 1), 9-13.

via grobid
Yamada, Y., Post, S. R., Wang, K., Tager, H. S., Bell, G. I. and Seino, S. (1992). Cloning and functional character- isation of a family of human and mouse somatostatin receptors expressed in brain; gastrointestinal tract and liver. Proc. Natl. Acad. Sci., USA, 78(87), 3930-3934.

via grobid
Srikant, C. B. and Patel, Y. C. (1992). Somatostatin receptors. Identification and characterisation in brain membranes. Proct. Natl. Acad. Sci., USA, 78, 1183 1193.

via grobid
Miller, C. V., Preston, Sr., Woodhouse, L. F., Farmery, S. M. and Primrose, J. H. (1993). Somatostatin binding in human gastrointestinal tissues: effects of cations and somatostatin analogues. Gut., 34, 1351-1356.

via grobid
Marbach, P., Andrew, H., Azria, M. et al. (1988). Chemical structure and pharmacodynamic properties of SMS 201-995 (Sandostatin) in the treatment of acromegaly. In "The Treatment of Acromegaly", Berlin, Springer, 53-60.

via grobid
Silvain, C., Carpentier, S., Sautereau, S. et al. (1991). A randomized trial of glypressin plus transdermal nitroglycerin versus octreotide in the control of acute variceal haemorrhage. Hepatology, 14, 1339.

via grobid
Jenkins, S. A., Copeland, G., Sutton, R., Kingsnorth, A. N. and Shields, R. (1992). Octreotide (SMS) versus sclerotherapy for variceal bleeding: preliminary re- sults. Br. J. Surg., 79, 1224.
Showing 1 - 30 of 31 references  next »